Diabetic hypertensive patients: improving their prognosis

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Diabetes mellitus presents significant vascular complications.
• Hypertension exacerbates diabetic progression to end-stage renal disease and cardiovascular events.
• Blood glucose and blood pressure control are key predictors of renal outcomes in diabetic patients.

Purpose of the Study:

• To review the role of antihypertensive medications in preserving renal function in diabetic patients.
• To emphasize the importance of blood pressure control in managing diabetic nephropathy.
• To discuss the potential benefits of fixed-dose combinations for medication compliance.

Main Methods:

• Review of recent studies on antihypertensive medications in diabetic patients.
• Analysis of data on the impact of blood pressure levels on renal function.
• Evaluation of specific drug classes, including ACE inhibitors and calcium-channel blockers.

Main Results:

• Angiotensin-converting enzyme (ACE) inhibitors are effective initial agents for blood pressure control in hypertensive diabetics.
• Nondihydropyridine calcium-channel blockers slow renal function decline in non-insulin-dependent diabetes mellitus (NIDDM) nephropathy.
• Blood pressure reduction to <130/85 mm Hg retards diabetic renal disease progression.

Conclusions:

• Achieving low blood pressure targets is paramount for preserving renal function in diabetic patients.
• Medication choice is secondary to achieving target blood pressure levels.
• Fixed-dose combinations of antihypertensive agents may improve goal achievement and patient compliance.